THE INSULIN SPARING EFFECT OF METFORMIN IN INSULIN-TREATED DIABETIC-PATIENTS

被引:0
|
作者
SLAMA, G
机构
来源
DIABETES & METABOLISM | 1991年 / 17卷 / 1BIS期
关键词
METFORMIN; INSULIN REQUIREMENT; INSULIN DEPENDENT DIABETES;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Since metformin became available for therapeutic utilisation, more than 30 years ago, it has been found that the compound was able to reduce hyperglycaemia in diabetic subjects without any stimulation of B cell secretion. The mechanism(s) of action of this drug has been better clarified these last 5-10 years even if all its aspects are not yet fully elucidated. What has been established, however, since the begining of its clinical use, is that metformin can act in the presence of insulin in "facilitating" its effects. This had lead some authors to investigate the possible synergie effect of metformin added to insulin therapy. Some studies have thus shown that insulin requirements were significantly decreased during the administration of biguanides, and effect which seemed to be maximal shortly after commencing the drug. Some authors have also claimed that biguanides smooth our blood glucose profiles in brittle diabetes, but this is denied by others. A decrease in insulin requirements may be of interest in diminishing peripheral hyperinsulinism and its possible consequences. It remains questionnable whether the addition of metformin in the long term is to be recommended in Type 1 diabetic patients. However, such a constatation of decrease insulin requirements can help in the understanding of the clinical significance of metformin's actions in diabetes (impact on insulin resistance, receptor and post-receptor effects).
引用
收藏
页码:241 / 243
页数:3
相关论文
共 50 条
  • [1] THE INSULIN-SPARING EFFECT OF METFORMIN IN INSULIN-TREATED DIABETIC-PATIENTS
    GOLAY, A
    GUILLETDAUPHINE, N
    FENDEL, A
    JUGE, C
    ASSAL, JP
    [J]. DIABETES-METABOLISM REVIEWS, 1995, 11 : S63 - S67
  • [2] DERANGEMENTS OF INSULIN KINETICS IN INSULIN-TREATED DIABETIC-PATIENTS
    NAVALESI, R
    BENZI, L
    PACI, A
    LENZI, S
    TALLARIGO, L
    MATTEUCCI, E
    CECCHETTI, P
    MASONI, A
    [J]. DIABETOLOGIA, 1982, 23 (03) : 301 - 301
  • [3] EFFECT OF GLIBENCLAMIDE IN INSULIN-TREATED DIABETIC-PATIENTS WITH A RESIDUAL INSULIN-SECRETION
    MAUERHOFF, T
    KETELSLEGERS, JM
    LAMBERT, AE
    [J]. DIABETES & METABOLISM, 1986, 12 (01): : 34 - 38
  • [4] SPORTS PRACTICE FOR INSULIN-TREATED DIABETIC-PATIENTS
    JANDRAIN, B
    PIRNAY, F
    SCHEEN, A
    LEFEBVRE, PJ
    [J]. DIABETES & METABOLISM, 1988, 14 (02) : 127 - 135
  • [5] COUNTERREGULATORY HORMONES IN CHRONICALLY INSULIN-TREATED DIABETIC-PATIENTS - EFFECT OF 2 TYPES OF INSULIN
    CORCOS, AP
    WEIDENFELD, J
    [J]. ISRAEL JOURNAL OF MEDICAL SCIENCES, 1986, 22 (06): : 499 - 499
  • [6] CLINICAL SIGNIFICANCE OF INSULIN-ANTIBODIES IN INSULIN-TREATED DIABETIC-PATIENTS
    VANHAEFTEN, TW
    [J]. DIABETES CARE, 1989, 12 (09) : 641 - 648
  • [7] ERYTHROCYTE AND MONOCYTE INSULIN-RECEPTORS IN INSULIN-TREATED DIABETIC-PATIENTS
    BROWN, DC
    KURTZ, AB
    MATTHEWS, JA
    NABARRO, JDN
    [J]. DIABETOLOGIA, 1982, 22 (05) : 383 - 383
  • [8] POSITIVE COOPERATIVITY OF ANTI-INSULIN ANTIBODIES IN INSULIN-TREATED DIABETIC-PATIENTS
    WU, W
    LANDAHL, H
    NOLTE, M
    SANZ, N
    KARAM, JH
    [J]. DIABETES, 1983, 32 : A152 - A152
  • [9] Effect of metformin on fibrinolytic parameters in insulin-treated, type 2 diabetic patients
    Gin, H
    Roudaut, MF
    Vergnot, V
    Baillet, L
    Rigalleau, V
    [J]. DIABETES & METABOLISM, 2003, 29 (05) : 505 - 508
  • [10] FREQUENCY OF CANCER AMONG INSULIN-TREATED DIABETIC-PATIENTS IN DENMARK
    GREEN, A
    JENSEN, OM
    [J]. DIABETOLOGIA, 1985, 28 (03) : 128 - 130